Cargando...

Flibanserin for hypoactive sexual desire disorder: place in therapy

The pathophysiology, diagnosis and treatment of female sexual interest in pre- and post-menopausal women present a complex arena for patients and physicians to navigate. Flibanserin was the first pharmacologic treatment, approved by the United States Food and Drug Administration in August 2015, for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Chronic Dis
Autores principales: Gelman, Faina, Atrio, Jessica
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5298357/
https://ncbi.nlm.nih.gov/pubmed/28203348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316679933
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!